Works matching IS 02724391 AND DT 2010 AND VI 71 AND IP 7
Results: 7
Managing high-potency active pharmaceutical ingredients-A drug sponsor's guide.
- Published in:
- Drug Development Research, 2010, v. 71, n. 7, p. 420, doi. 10.1002/ddr.20385
- By:
- Publication type:
- Article
Anti-inflammatory and antiproliferative activities of crude extract and its fractions of the defensive secretion from the Mediterranean sponge, Spongia officinalis.
- Published in:
- Drug Development Research, 2010, v. 71, n. 7, p. 412, doi. 10.1002/ddr.20392
- By:
- Publication type:
- Article
State-of-the-art process for the safe synthesis of anticancer drugs.
- Published in:
- Drug Development Research, 2010, v. 71, n. 7, p. 439, doi. 10.1002/ddr.20384
- By:
- Publication type:
- Article
Ligand binding sensitivity of the extracellular loop two of the cannabinoid receptor 1.
- Published in:
- Drug Development Research, 2010, v. 71, n. 7, p. 404, doi. 10.1002/ddr.20388
- By:
- Publication type:
- Article
Metabolic limitations of the use of nucleoside analogs in cancer therapy may be overcome by application of nanoparticles as drug carriers: A review.
- Published in:
- Drug Development Research, 2010, v. 71, n. 7, p. 383, doi. 10.1002/ddr.20390
- By:
- Publication type:
- Article
Pharmaceutical development of IPI-504, an Hsp90 inhibitor and clinical candidate for the treatment of cancer.
- Published in:
- Drug Development Research, 2010, v. 71, n. 7, p. 429, doi. 10.1002/ddr.20383
- By:
- Publication type:
- Article
A study design with conditional, serially assessed co-primary endpoints: An application to a single-arm, pilot non-Hodgkin's lymphoma trial.
- Published in:
- Drug Development Research, 2010, v. 71, n. 7, p. 395, doi. 10.1002/ddr.20387
- By:
- Publication type:
- Article